Open AccessSystemic Therapy for Atopic Dermatitis in Older Adults and Adults With Comorbidities: A Scoping Review and International Eczema Council Survey
Author(s) -
Aaron M. Drucker,
Megan Lam,
Carsten Flohr,
Jacob P. Thyssen,
Kenji Kabashima,
Robert Bissonnette,
Ncoza Cordelia Dlova,
Valéria Aoki,
Max Chen,
Joshua Yu,
Jie Zhu,
Robert Micieli,
Audrey Nosbaum
Publication year - 2022
Publication title -
dermatitis
Language(s) - English
Resource type - Journals
eISSN - 2162-5220
pISSN - 1710-3568
DOI - 10.1097/der.0000000000000845
Subject(s) - medicine , dupilumab , systemic therapy , atopic dermatitis , azathioprine , medline , population , observational study , comorbidity , disease , systemic vasculitis , intensive care medicine , dermatology , cancer , vasculitis , environmental health , breast cancer , political science , law
Clinical trials of systemic therapies for atopic dermatitis (AD) often exclude patients based on age and comorbidities.